Literature DB >> 2598826

Amounts and modulation of actin mRNAs in mouse oocytes and embryos.

R Bachvarova1, E M Cohen, V De Leon, K Tokunaga, S Sakiyama, B V Paynton.   

Abstract

In order to measure the content of beta- and gamma-actin mRNA in mouse oocytes and ovulated eggs, Northern and slot blots were hybridized to complementary RNA probes transcribed from mouse isotype-specific cDNA sequences. The blots included samples of isotype-specific sense strand RNA standards prepared from the same cDNA sequences. Total actin mRNA content was estimated to be 40 fg per preovulatory full-grown oocyte or egg, consisting of one-third beta-actin mRNA and two-thirds gamma-actin mRNA. Ninety per cent of the actin mRNA is on polysomes in full-grown oocytes. The per cent of actin mRNA in polysomal mRNA is similar to the per cent of actin in newly synthesized proteins. Measurements on other developmental stages showed that, in mid-growth-phase oocytes, each actin mRNA reaches a level twofold higher than in full-grown oocytes. Thereafter, all modulations of the two isotypic mRNAs occur in parallel; that is, they are maintained at constant levels during the late growth phase (oocytes from females 8-14 days old); gradually degraded in oocytes that have completed their rapid growth phase (oocytes from females 15-18 days old), in maturing oocytes, and in 1- and 2-cell embryos; and deadenylated after about 7 h of progression into meiotic maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598826     DOI: 10.1242/dev.106.3.561

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  12 in total

1.  Transcriptional selectivity in early mouse embryos: a qualitative study.

Authors:  C Bonnerot; M Vernet; G Grimber; P Briand; J F Nicolas
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

2.  Masking, unmasking, and regulated polyadenylation cooperate in the translational control of a dormant mRNA in mouse oocytes.

Authors:  A Stutz; B Conne; J Huarte; P Gubler; V Völkel; P Flandin; J D Vassalli
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

Review 3.  Regulation of actin isoforms in cellular and developmental processes.

Authors:  Anna S Kashina
Journal:  Semin Cell Dev Biol       Date:  2020-01-27       Impact factor: 7.727

4.  The oocyte-to-embryo transition in mouse: past, present, and future.

Authors:  Richard M Schultz; Paula Stein; Petr Svoboda
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

5.  Murine protein serine/threonine kinase 38 stimulates TGF-beta signaling in a kinase-dependent manner via direct phosphorylation of Smad proteins.

Authors:  Hyun-A Seong; Haiyoung Jung; Hyunjung Ha
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

6.  Stage-specific localization of cytoskeletal actin mRNA in murine seminiferous tubules and intestinal epithelia as demonstrated by in-situ hybridization.

Authors:  S Sakiyama; Y Nakamura; K Tokunaga; H Takazawa; Y Ohwaki; T Nagano
Journal:  Cell Tissue Res       Date:  1989-11       Impact factor: 5.249

7.  Mouse Sebox homeobox gene expression in skin, brain, oocytes, and two-cell embryos.

Authors:  M Cinquanta; A C Rovescalli; C A Kozak; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  The stem-loop binding protein regulates translation of histone mRNA during mammalian oogenesis.

Authors:  Patrick Allard; Qin Yang; William F Marzluff; Hugh J Clarke
Journal:  Dev Biol       Date:  2005-10-01       Impact factor: 3.582

9.  Expression of the amyloid precursor protein gene in mouse oocytes and embryos.

Authors:  S Fisher; J D Gearhart; M L Oster-Granite
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

10.  Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation.

Authors:  J Carlos Villaescusa; Claudia Buratti; Dmitry Penkov; Lisa Mathiasen; Jesús Planagumà; Elisabetta Ferretti; Francesco Blasi
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.